Drawing for FACTORING IN THE HUMAN.

USPTO serial 86137313

FACTORING IN THE HUMAN.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SOBRAL, CHRISTINA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FACTORING IN THE HUMAN.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

MICHELE H. BOWMAN ABBOTT LABORATORIES100 ABBOTT PARK RDABBOTT PARK, IL 60064-6093UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Research laboratory analyzers for measuring, testing and analyzing blood, bodily fluids and/or tissue; Laboratory instruments for in vitro diagnostic testing and/or analysis; Laboratory equipment, namely, laboratory test and collection kits used in connection with in vitro diagnostics consisting of test tubes and microscope slides for use in the field of medical diagnostics; Laboratory test and collection kits consisting of test tubes and microscope slides used in connection with in vitro diagnostics; Molecular diagnostic systems comprised of sequencers, spectrometers, optical, electrical and electromechanical sensors and computers, for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; Automated clinical molecular laboratory instruments, namely, homogenizers; Laboratory sample extraction instruments, namely, nucleic acid extractors; Laboratory instruments for microbial screening and identification; Laboratory apparatus, namely, molecular diagnostic sensors for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; Data management and laboratory automation systems comprising of, namely, automation equipment to automate the decapping and sorting of laboratory samples and tubes, online sample storage, sample transport, centrifugation, sample resealing and desealing; and aliquoting, data management and laboratory computer hardware for use in the field of medical diagnostics; Computer hardware and software for front-end processing, instrument control, data analysis and reporting scanners for use in the field of medical diagnostics; Data management software for medical diagnostic instruments; Data management software for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; Computer hardware and software for front-end processing, instrument control, data analysis and reporting for medical diagnostic instruments; Computer hardware and software for front-end processing, instrument control, data analysis and reporting for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; Computer software and hardware for managing interface between medical diagnostic laboratory instruments; Computer software and hardware for managing medical diagnostic laboratory workflow; Laboratory information management software and hardware for use in the field of medical diagnostics; Computer software and hardware for monitoring medical diagnostic instruments; Computer software and hardware for monitoring laboratory diagnostic instruments; Computer software and hardware for troubleshooting regarding medical diagnostic instruments; Computer software and hardware for troubleshooting regarding laboratory diagnostic instruments; Computer software for processing diagnostic medical testing data; Computer hardware and software for use in medical diagnostic testing; Computer hardware and software for remote monitoring of in vitro diagnostic instruments; Computer software and hardware for identification and analysis of nucleic acid sequences, nucleic acids for pathogen identity, drug resistance characteristics and forensic profiles; Computer software for front-end processing, instrument control, data analysis and reporting for molecular diagnostic instruments; Electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems, and related software; Providing electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems, and related softwareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 14, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 14, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 10, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 16, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 16, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 8, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 5, 2014ALIEASSIGNED TO LIE—
Oct 21, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 21, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Oct 21, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 21, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 21, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 19, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 18, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2014DOCKASSIGNED TO EXAMINER—
Dec 19, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance